-
Health Canada Advisory About Statins and Rhabdomyolysis Side Effect
July 2005 Statin Advisory Provides Patients With Important Safety Information On July 12, 2005 Health Canada issued an advisory about rhabdomyolysis being a serious side effect of all cholesterol-lowering drugs known as statins. Specifically,…
-
Recent Study Shows How Vioxx, Bextra, and Celebrex Can Damage Heart
A Theory of Why COX-2 Inhibitors Affect the Heart and Raise Heart Attack Risk In May 2005 it was reported that medical researchers affiliated with the University of Pennsylvania School of Medicine have…
-
FDA Mandates NAION Warning on Several Impotence and ED Drugs
Labels on Viagra, Cialis and Levitra are Changed to Address Blindness Issue On July 8, 2005 the FDA ordered warnings be put on the package insert labels of Viagra, Cialis, and Levitra to the…
-
Health Canada Advisory Panel Supports Return of Painkiller Vioxx to Market
Canadian Panel Votes Against Bextra Due to Increased Risk of Serious Skin Reactions On July 7, 2005, a panel of medical experts advised Health Canada officials that, in its opinion, the arthritis drug and…
-
A Review of the FDA’s Adverse Event Reporting System Database: 1969 to 2002
2.3 million ADE Case Reports Involving Approximately 6000 Prescription Drugs In a recent edition of the Archives of Internal Medicine (Arch Intern Med.2005;165:1363-1369) two researchers from the FDA’s Office of Drug Safety analyzed all…
-
Vioxx Trial Scheduled for July 11 in Texas Given Green Light
Texas Judge Denies Merck’s Request to Delay First Vioxx Case On July 5, 2005 a Texas judge declined a request by lawyers for Merck & Co. to postpone the nation’s first Vioxx trial, which…
